Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment
Overview
Authors
Affiliations
Background: Human immunodeficiency virus (HIV) infection induces epigenetic age acceleration (EAA), but it remains unclear whether epigenetic aging continues to accelerate during successful antiretroviral therapy (ART) and prolonged virological suppression.
Methods: We longitudinally analyzed 63 long-term aviremic HIV-infected adults. Using blood DNA methylation patterns, we calculated EAA measures based on 3 epigenetic clocks (Horvath's clock, PhenoAge, and GrimAge). We recorded the emergence of serious AIDS-related and non-AIDS-related events throughout the study to assess its association with EAA.
Results: All participants were on stable ART and were virologically suppressed. After 4 years of follow-up, PhenoAge-EAA and GrimAge-EAA showed no differences, whereas Horvath-EAA slightly decreased (median difference, -0.53 years; P = .015). Longitudinal changes in EAA measures were independent of changes in CD4 cell counts, the ART regimen, or other HIV-related factors. Nineteen percent of participants experienced a serious clinical event during the study. Horvath-EAA was significantly higher at baseline in participants with clinical events (P = .027). After adjusting for confounders, we found a trend toward an association of higher levels of all EAA measures at baseline with serious clinical events.
Conclusions: Epigenetic aging did not accelerate in long-term aviremic HIV-infected adults after 4 years of successful ART. EAA measures deserve further study as potential tools for predicting clinical events.
Li L, Yu F, Yang S, Li H, Tang Y, Ma C BMC Infect Dis. 2025; 25(1):290.
PMID: 40021989 PMC: 11869689. DOI: 10.1186/s12879-025-10511-7.
Grossbach A, Suderman M, Huls A, Lussier A, Smith A, Walton E Clin Epigenetics. 2024; 16(1):187.
PMID: 39707425 PMC: 11662605. DOI: 10.1186/s13148-024-01784-x.
Intestinal Microbiota and Aging in People with HIV-What We Know and What We Don't.
Islam S, Singh S, Keshavarzian A, Abdel-Mohsen M Curr HIV/AIDS Rep. 2024; 22(1):9.
PMID: 39666149 PMC: 11874070. DOI: 10.1007/s11904-024-00717-w.
Grossbach A, Suderman M, Huls A, Lussier A, Smith A, Walton E Res Sq. 2024; .
PMID: 38947070 PMC: 11213208. DOI: 10.21203/rs.3.rs-4482915/v1.
Zhang J, Sehl M, Shih R, Breen E, Li F, Lu A Front Bioinform. 2024; 4:1357889.
PMID: 38855142 PMC: 11157437. DOI: 10.3389/fbinf.2024.1357889.